...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Long term follow-up and risk of breast cancer after a radial scar or complex sclerosing lesion has been identified in a benign open breast biopsy.
【24h】

Long term follow-up and risk of breast cancer after a radial scar or complex sclerosing lesion has been identified in a benign open breast biopsy.

机译:在良性开放性乳房活检中已确定了放射状疤痕或复杂硬化性病变后的长期随访和患乳腺癌的风险。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: Radial scars (RS)/complex sclerosing lesions (CSL) are rare, benign breast lesions of unknown aetiology. Associations with breast cancer have been suggested particularly with larger lesions. This study aims to identify the risk of developing subsequent breast cancer after excision of a benign RS/CSL with respect to lesion size and compared to expected rates in the normal UK population. METHODS: A prospective cohort analysis was performed on patients diagnosed with RS/CSL in benign, open breast biopsy specimens over a 20-year period. The rate of subsequent breast cancer development was compared to expected rates in the normal UK population. Subjects were divided into two groups according to lesion size and the rates of subsequent breast cancer compared. RESULTS: 149 women without proliferative breast disease were followed for an average of 68 months. Five women developed subsequent cancer, equating to a rate of 0.84% per year. This compares to 0.32% per year in the normal population (RR 2.6, 95% CI 0.86-6.0). There were two subsequent cancers in the RS group and three subsequent cancers in the CSL group, P = 0.64. CONCLUSIONS: The study finds no evidence to suggest that lesions greater than 10 mm (CSL) have any greater risk of developing cancer after excision than those below 10 mm (RS). Women treated for RS/CSL do not need any additional follow-up beyond routine mammographic breast screening. Additional surveillance should only be performed if there is associated pathology indicating an increased risk of subsequent malignancy.
机译:目的:放射疤痕(RS)/复杂硬化性病变(CSL)是罕见的,病因不明的良性乳腺病变。已经提出了与乳腺癌的关联,特别是对于较大的病变。这项研究的目的是就病变大小和与正常英国人群的预期患病率进行比较,确定切除良性RS / CSL后患上继发乳腺癌的风险。方法:对20年来在良性,开放性乳腺活检标本中诊断为RS / CSL的患者进行了前瞻性队列分析。随后的乳腺癌发生率与英国正常人群的预期发生率进行了比较。根据病变大小和随后的乳腺癌发生率将受试者分为两组。结果:149名无增生性乳腺疾病的妇女平均随访68个月。五名妇女随后罹患癌症,相当于每年0.84%。相比之下,正常人群每年的比例为0.32%(RR 2.6,95%CI 0.86-6.0)。 RS组中有两个随后的癌症,CSL组中有三个随后的癌症,P = 0.64。结论:研究发现没有证据表明,大于10毫米(CSL)的病变在切除后比10毫米(RS)以下的病变具有更大的患癌风险。经过RS / CSL治疗的女性除了常规的乳房X线乳腺筛查外,不需要任何其他随访。仅当存在相关的病理学表明随后发生恶性肿瘤的风险增加时,才应进行额外的监视。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号